{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:20:21Z","timestamp":1791069621477,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ahj.2014.03.018","type":"journal-article","created":{"date-parts":[[2014,4,5]],"date-time":"2014-04-05T21:00:23Z","timestamp":1396731623000},"page":"789-795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Carcinoid heart disease: Current understanding and future directions"],"prefix":"10.1016","volume":"167","author":[{"given":"Chirdeep","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo O.","family":"Escarcega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred A.","family":"Bove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ahj.2014.03.018_bb0005","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/hrt.2004.040329","article-title":"Carcinoid heart disease: presentation, diagnosis, and management","volume":"90","author":"Fox","year":"2004","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.ahj.2014.03.018_bb0010","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/1097-0142(20011015)92:8<2204::AID-CNCR1564>3.0.CO;2-R","article-title":"Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden","volume":"92","author":"Hemminki","year":"2001","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ahj.2014.03.018_bb0015","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ahj.2014.03.018_bb0020","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2005.03.038","article-title":"Current status of gastrointestinal carcinoids","volume":"128","author":"Modlin","year":"2005","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.ahj.2014.03.018_bb0025","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0735-1097(02)02109-5","article-title":"Metastatic carcinoid tumor to the heart: echocardiographic-pathologic study of 11 patients","volume":"40","author":"Pandya","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2014.03.018_bb0030","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.87.4.1188","article-title":"Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients","volume":"87","author":"Pellikka","year":"1993","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ahj.2014.03.018_bb0035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pcad.2006.12.002","article-title":"Carcinoid heart disease","volume":"49","author":"Bernheim","year":"2007","journal-title":"Prog Cardiovasc Dis"},{"issue":"7","key":"10.1016\/j.ahj.2014.03.018_bb0040","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.amjcard.2007.11.056","article-title":"Prevalence of patent foramen ovale and usefulness of percutaneous closure device in carcinoid heart disease","volume":"101","author":"Mansencal","year":"2008","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ahj.2014.03.018_bb0045","doi-asserted-by":"crossref","first-page":"1129.e1","DOI":"10.1016\/j.ahj.2006.02.019","article-title":"Assessment of patent foramen ovale in carcinoid heart disease","volume":"15","author":"Mansencal","year":"2006","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.ahj.2014.03.018_bb0050","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijcard.2008.02.019","article-title":"Carcinoid heart disease","volume":"129","author":"Gustafsson","year":"2008","journal-title":"Int J Cardiol"},{"issue":"7332","key":"10.1016\/j.ahj.2014.03.018_bb0055","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(64)92907-1","article-title":"Release of a kinin peptide in the carcinoid syndrome","volume":"1","author":"Oates","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2014.03.018_bb0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1741-7015-6-34","article-title":"Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals","volume":"6","author":"Dahl","year":"2008","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.ahj.2014.03.018_bb0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0026-895X(24)26444-0","article-title":"Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine","volume":"57","author":"Fitzgerald","year":"2000","journal-title":"Mol Pharmacol"},{"issue":"23","key":"10.1016\/j.ahj.2014.03.018_bb0070","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","article-title":"Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications","volume":"102","author":"Rothman","year":"2000","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ahj.2014.03.018_bb0075","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S1474-4422(07)70218-1","article-title":"Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease","volume":"6","author":"Antonini","year":"2007","journal-title":"Lancet Neurol"},{"issue":"13","key":"10.1016\/j.ahj.2014.03.018_bb0080","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/mds.21639","article-title":"Meta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists","volume":"22","author":"Simonis","year":"2007","journal-title":"Mov Disord"},{"issue":"9130","key":"10.1016\/j.ahj.2014.03.018_bb0085","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(98)02286-7","article-title":"Carcinoid tumour","volume":"352","author":"Caplin","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2014.03.018_bb0090","series-title":"Harrison's principles and practices of internal medicine","first-page":"1535","article-title":"Endocrine tumors of the gastrointestinal tract and pancreas","author":"Kaplan","year":"1994"},{"issue":"1","key":"10.1016\/j.ahj.2014.03.018_bb0095","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0002-9149(98)00798-X","article-title":"Heart rate variability in carcinoid heart disease","volume":"83","author":"Hoffmann","year":"1999","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2014.03.018_bb0100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00392-006-0463-y","article-title":"Atrial fibrillation in carcinoid heart disease: the role of serotonin. A review of the literature","volume":"96","author":"Langer","year":"2007","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2014.03.018_bb0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/02841869309083912","article-title":"Metastatic carcinoid tumors and the malignant carcinoid syndrome","volume":"32","author":"Kvols","year":"1993","journal-title":"Acta Oncol"},{"issue":"5","key":"10.1016\/j.ahj.2014.03.018_bb0110","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/clinchem\/32.5.840","article-title":"Urinary serotonin in the diagnosis of carcinoid tumors","volume":"32","author":"Feldman","year":"1986","journal-title":"Clin Chem"},{"issue":"7","key":"10.1016\/j.ahj.2014.03.018_bb0115","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/cncr.11226","article-title":"Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor","volume":"97","author":"Zuetenhorst","year":"2003","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.ahj.2014.03.018_bb0120","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021451","article-title":"Factors associated with progression of carcinoid heart disease","volume":"348","author":"Moller","year":"2003","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ahj.2014.03.018_bb0125","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.amjcard.2010.12.025","article-title":"Risk factors for the development and progression of carcinoid heart disease","volume":"107","author":"Bhattacharyya","year":"2011","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2014.03.018_bb0130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jso.20179","article-title":"Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract","volume":"89","author":"Rorstad","year":"2005","journal-title":"J Surg Oncol"},{"issue":"7","key":"10.1016\/j.ahj.2014.03.018_bb0135","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.amjcard.2008.05.047","article-title":"Usefulness of N-terminal pro-brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease","volume":"102","author":"Bhattacharyya","year":"2008","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2014.03.018_bb0140","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1245\/s10434-006-9148-z","article-title":"Biomarkers predict outcomes following cytoreductive surgery for hepatic metastases from functional carcinoid tumors","volume":"14","author":"Jensen","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ahj.2014.03.018_bb0145","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s00268-004-7384-6","article-title":"Chromogranin A, a marker of the therapeutic success of resection of neuroendocrine liver metastases: preliminary report","volume":"28","author":"Sondenaa","year":"2004","journal-title":"World J Surg"},{"issue":"26","key":"10.1016\/j.ahj.2014.03.018_bb0150","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2008.18.7047","article-title":"Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor","volume":"27","author":"Korse","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ahj.2014.03.018_bb0155","first-page":"625","article-title":"Incidence and evolution of carcinoid syndrome in the heart","volume":"6","author":"Moyssakis","year":"1997","journal-title":"J Heart Valve Dis"},{"issue":"5","key":"10.1016\/j.ahj.2014.03.018_bb0160","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/01.CIR.66.5.1059","article-title":"Carcinoid heart disease: diagnosis by two-dimensional echocardiography","volume":"66","author":"Howard","year":"1982","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ahj.2014.03.018_bb0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCIMAGING.109.886846","article-title":"Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI","volume":"3","author":"Bhattacharyya","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.ahj.2014.03.018_bb0170","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.echo.2011.02.009","article-title":"Evaluation of right ventricular dysfunction by myocardial strain echocardiography in patients with intestinal carcinoid disease","volume":"24","author":"Haugaa","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"issue":"21","key":"10.1016\/j.ahj.2014.03.018_bb0175","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1161\/CIRCULATIONAHA.105.553750","article-title":"Prognosis of carcinoid heart disease: analysis of 200 cases over two decades","volume":"112","author":"Moller","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ahj.2014.03.018_bb0180","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1200\/JCO.1999.17.2.600","article-title":"Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome","volume":"17","author":"Rubin","year":"1999","journal-title":"J Clin Oncol"},{"issue":"Suppl. 2","key":"10.1016\/j.ahj.2014.03.018_bb0185","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1093\/annonc\/10.suppl_2.S31","article-title":"Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: future outlook","volume":"10","author":"Eriksson","year":"1999","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ahj.2014.03.018_bb0190","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jso.10062","article-title":"Regression of metastatic carcinoid tumors with octreotide therapy: two case reports and a review of the literature","volume":"79","author":"Leong","year":"2002","journal-title":"J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ahj.2014.03.018_bb0195","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/02841868709113712","article-title":"Cytotoxic treatment in patients with malignant carcinoid tumors. response to streptozocin\u2013alone or in combination with 5-FU","volume":"26","author":"Oberg","year":"1987","journal-title":"Acta Oncol"},{"issue":"4","key":"10.1016\/j.ahj.2014.03.018_bb0200","first-page":"627","article-title":"Treatment of metastasized midgut carcinoids with dacarbazine","volume":"90","author":"Ritzel","year":"1995","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ahj.2014.03.018_bb0205","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.COC.0000054535.19808.F4","article-title":"Topotecan in patients with advanced neuroendocrine tumors: a phase II study with significant hematologic toxicity","volume":"27","author":"Ansell","year":"2004","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ahj.2014.03.018_bb0210","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0735-1097(94)00374-Y","article-title":"Outcome of cardiac surgery for carcinoid heart disease","volume":"25","author":"Connolly","year":"1995","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ahj.2014.03.018_bb0215","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2293::AID-CNCR8>3.0.CO;2-E","article-title":"Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors","volume":"83","author":"Eriksson","year":"1998","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ahj.2014.03.018_bb0220","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1051-0443(99)70055-2","article-title":"Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms","volume":"10","author":"Brown","year":"1999","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"10.1016\/j.ahj.2014.03.018_bb0225","first-page":"1091","article-title":"Cytoreductive hepatic surgery for neuroendocrine tumors","volume":"108","author":"McEntee","year":"1990","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.ahj.2014.03.018_bb0230","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1072-7515(03)00230-8","article-title":"Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival","volume":"197","author":"Sarmiento","year":"2003","journal-title":"J Am Coll Surg"},{"issue":"12 Suppl. 1","key":"10.1016\/j.ahj.2014.03.018_bb0235","first-page":"I51","article-title":"Carcinoid heart disease: impact of pulmonary valve replacement in right ventricular function and remodeling","volume":"106","author":"Connolly","year":"2002","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.ahj.2014.03.018_bb0240","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jacc.2007.12.036","article-title":"Early and late results of valvular surgery for carcinoid heart disease","volume":"51","author":"Castillo","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2014.03.018_bb0245","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejcts.2010.10.035","article-title":"Outcomes, risks and complications of cardiac surgery for carcinoid heart disease","volume":"40","author":"Bhattacharyya","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"issue":"12 Suppl. 1","key":"10.1016\/j.ahj.2014.03.018_bb0250","doi-asserted-by":"crossref","first-page":"I36","DOI":"10.1161\/hc37t1.094898","article-title":"Surgical management of left-sided carcinoid heart disease","volume":"104","author":"Connolly","year":"2001","journal-title":"Circulation"},{"issue":"6 Pt 1","key":"10.1016\/j.ahj.2014.03.018_bb0255","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/0002-8703(91)90045-J","article-title":"Bioprosthetic tricuspid valve stenosis associated with extensive plaque deposition in carcinoid heart disease","volume":"121","author":"Ridker","year":"1991","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.ahj.2014.03.018_bb0260","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/0002-9149(83)90357-0","article-title":"Long-term results of tricuspid valve replacement and the problem of prosthetic valve thrombosis","volume":"51","author":"Thorburn","year":"1983","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2014.03.018_bb0265","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-5223(19)37666-4","article-title":"Porcine heterograft valve replacement in carcinoid heart disease","volume":"81","author":"Schoen","year":"1981","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.ahj.2014.03.018_bb0270","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004311-199703540-00009","article-title":"Anesthesia for patients with carcinoid syndrome","volume":"35","author":"Vaughan","year":"1997","journal-title":"Int Anesthesiol Clin"},{"issue":"5","key":"10.1016\/j.ahj.2014.03.018_bb0275","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/0888-6296(88)90060-9","article-title":"Anesthetic management of patients with carcinoid heart disease undergoing cardiac surgery: two case reports and a review of previous experience","volume":"2","author":"Ockert","year":"1988","journal-title":"J Cardiothorac Anesth"},{"issue":"4","key":"10.1016\/j.ahj.2014.03.018_bb0280","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/BF03020948","article-title":"Orthotopic liver transplantation for carcinoid tumour metastatic to the liver: anesthetic management","volume":"47","author":"Claure","year":"2000","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.ahj.2014.03.018_bb0285","series-title":"Pharmacology and physiology in anesthetic practice","year":"1999"},{"issue":"1","key":"10.1016\/j.ahj.2014.03.018_bb0290","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00000542-198701000-00021","article-title":"Carcinoid crisis during anesthesia: successful treatment with a somatostatin analogue","volume":"66","author":"Marsh","year":"1987","journal-title":"Anesthesiology"},{"issue":"24","key":"10.1016\/j.ahj.2014.03.018_bb0295","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1161\/CIRCULATIONAHA.107.701367","article-title":"Carcinoid heart disease","volume":"116","author":"Bhattacharyya","year":"2007","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ahj.2014.03.018_bb0300","first-page":"115","article-title":"Balloon dilation of tricuspid and pulmonary valves in carcinoid heart disease","volume":"20","author":"Onate","year":"1993","journal-title":"Tex Heart Inst J"},{"issue":"6","key":"10.1016\/j.ahj.2014.03.018_bb0305","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/hrt.67.6.450","article-title":"Failure of balloon dilatation of the pulmonary valve in carcinoid pulmonary stenosis","volume":"67","author":"Grant","year":"1992","journal-title":"Br Heart J"},{"issue":"6","key":"10.1016\/j.ahj.2014.03.018_bb0310","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.0007-1323.2001.01798.x","article-title":"Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome","volume":"88","author":"Westberg","year":"2001","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.ahj.2014.03.018_bb0315","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1309\/AJCP9H1OTMUCSKQW","article-title":"Neuroendocrine carcinomas of the lung: a critical analysis","volume":"131","author":"Moran","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.ahj.2014.03.018_bb0320","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/ijc.25441","article-title":"VEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis","volume":"128","author":"Silva","year":"2011","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ahj.2014.03.018_bb0325","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000337257","article-title":"Synergistic effects of erlotinib and everolimus on bronchial carcinoids and large-cell neuroendocrine carcinomas with activated EGFR\/AKT\/mTOR pathway","volume":"96","author":"Bago-Horvath","year":"2012","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.ahj.2014.03.018_bb0330","first-page":"382","article-title":"Advances in the systemic treatment of neuroendocrine tumors in the era of molecular therapy","volume":"13","author":"Leung","year":"2013","journal-title":"Anticancer Agents Med Chem"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870314001641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870314001641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:51:49Z","timestamp":1757569909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870314001641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0002870314001641"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2014.03.018","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carcinoid heart disease: Current understanding and future directions","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2014.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}